Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2021
∙
Martin, C. Domingo, C. Bottieau, E. Buonfrate, D. De Wit, S. Van Laethem, Y. Dauby, N.
Immunogenicity and duration of protection after yellow fever vaccine in people living with human immunodeficiency virus: a systematic review
2021
∙
Schenk, J. Abrams, S. Theeten, H. Van Damme, P. Beutels, P. Hens, N.
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis
2021
∙
Becerril-Gaitan, Andrea Vaca-Cartagena, Bryan F. Ferrigno, Ana S. Mesa-Chavez, Fernanda Barrientos-Gutiérrez, Tonatiuh Tagliamento, Marco Lambertini, Matteo Villarreal-Garza, Cynthia
Immunogenicity and Risk of SARS-CoV-2 Infection after COVID-19 Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis
2021
∙
Liang, Y. Jing-Xia, G. Ma, L. Ni, L. Chaolie, R. Zhou, J. Guo-Yang, L.
Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis
2021
∙
Kalaij, A. G. I. Dirjayanto, V. J. Yusuf, S. M. Nelwan, E. J.
Immunogenicity and safety of adenovirus-based vector vaccines for COVID-19: a systematic review and meta-analysis
2021
∙
Diallo, A. Carlos-Bolumbu, M. Cervantes-Gonzalez, M. Wozniak, V. Diallo, M. H. Diallo, B. D. Delamou, A. Galtier, F.
Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis
2021
∙
Egunsola, O. Clement, F. Taplin, J. Mastikhina, L. Li, J. W. Lorenzetti, D. L. Dowsett, L. E. Noseworthy, T.
Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis
2021
∙
Keller, M. Pittet, L. F. Zimmermann, P.
Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review
2021
∙
Lau, Oscar Vadlamudi, Nirma Khatri
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
2021
∙
Teh, Joanne S. K. Coussement, Julien Neoh, Zoe C. F. Spelman, Tim Lazarakis, Smaro Slavin, Monica A. Teh, Benjamin W.
Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: a systematic review and meta-analysis
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register